Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile in Patients Receiving Adjuvant Therapy With FOLFOX-6 After Curative Resection of Colon Cancer

NCT01472601 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01472601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01472601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile in Patients Receiving Adjuvant Therapy With FOLFOX-6 After Curative Resection of Colon Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
May 24, 2011
Completion date
April 30, 2020
Enrollment
2,660 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer